Compare RCUS & HWKN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | RCUS | HWKN |
|---|---|---|
| Founded | 2015 | 1938 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Specialty Chemicals |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.2B | 2.7B |
| IPO Year | 2018 | 1995 |
| Metric | RCUS | HWKN |
|---|---|---|
| Price | $17.47 | $149.66 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 15 | 3 |
| Target Price | $41.00 | ★ $176.75 |
| AVG Volume (30 Days) | ★ 2.4M | 112.3K |
| Earning Date | 11-04-2026 | 10-26-2026 |
| Dividend Yield | N/A | ★ 0.53% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ 2.69 |
| Revenue | $247,000,000.00 | ★ $1,083,696,000.00 |
| Revenue This Year | N/A | $9.87 |
| Revenue Next Year | N/A | $5.43 |
| P/E Ratio | ★ N/A | $56.08 |
| Revenue Growth | N/A | ★ 11.21 |
| 52 Week Low | $17.43 | $116.05 |
| 52 Week High | $31.74 | $174.12 |
| Indicator | RCUS | HWKN |
|---|---|---|
| Relative Strength Index (RSI) | 34.56 | 58.51 |
| Support Level | N/A | $143.66 |
| Resistance Level | $19.63 | $156.63 |
| Average True Range (ATR) | 0.95 | 4.19 |
| MACD | 0.16 | -0.61 |
| Stochastic Oscillator | 10.96 | 5.66 |
Arcus Biosciences Inc is a late clinical-stage biopharmaceutical company focused on developing differentiated molecules for patients with cancer and inflammatory and autoimmune diseases. Its product pipeline includes Domvanalimab, Quemliclustat, Casdatifan, Zimberelimab, among others. The company operates in one reportable and operating segment, which is the business of developing and commercializing differentiated therapies.
Hawkins Inc manufactures and sells a variety of chemicals and ingredients. The firm organizes itself into three segments based on the product type. The Industrial Solutions segment, provides industrial chemicals, products and services to industries such as industrial manufacturing, chemical processing, electronics, energy, plating, and surface finishing. The water treatment segment, which generates the majority of revenue sells chemicals and equipment used to treat potable water, municipal and industrial wastewater, industrial process water, and non-residential swimming pool water. Food and Health Sciences segment specializes in processing and formulation solutions as well as ingredient distribution to manufacturers in the nutrition, food, pharmaceutical, and agricultural markets.